Ark Genomic Revolution Etf Price History

ARKG Etf  USD 24.11  0.14  0.58%   
Below is the normalized historical share price chart for ARK Genomic Revolution extending back to October 31, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ARK Genomic stands at 24.11, as last reported on the 18th of January 2025, with the highest price reaching 24.61 and the lowest price hitting 24.03 during the day.
3 y Volatility
41.58
200 Day MA
25.0735
1 y Volatility
37.12
50 Day MA
24.8202
Inception Date
2014-10-31
 
Yuan Drop
 
Covid
If you're considering investing in ARK Etf, it is important to understand the factors that can impact its price. At this point, ARK Genomic is not too volatile. ARK Genomic Revolution secures Sharpe Ratio (or Efficiency) of 0.008, which signifies that the etf had a 0.008% return per unit of return volatility over the last 3 months. We have found twenty-three technical indicators for ARK Genomic Revolution, which you can use to evaluate the volatility of the entity. Please confirm ARK Genomic's insignificant Risk Adjusted Performance, coefficient of variation of (9,543), and Mean Deviation of 2.2 to double-check if the risk estimate we provide is consistent with the expected return of 0.0224%.
  
ARK Etf price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.008

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsARKG

Estimated Market Risk

 2.81
  actual daily
25
75% of assets are more volatile

Expected Return

 0.02
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average ARK Genomic is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ARK Genomic by adding ARK Genomic to a well-diversified portfolio.
Average Mkt Cap Mil
2.3 K

ARK Genomic Etf Price History Chart

There are several ways to analyze ARK Genomic Revolution Etf price data. The simplest method is using a basic ARK candlestick price chart, which shows ARK Genomic price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 11, 202427.11
Lowest PriceNovember 15, 202422.66

ARK Genomic January 18, 2025 Etf Price Synopsis

Various analyses of ARK Genomic's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell ARK Etf. It can be used to describe the percentage change in the price of ARK Genomic from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of ARK Etf.
ARK Genomic Price Daily Balance Of Power(0.24)
ARK Genomic Price Action Indicator(0.28)
ARK Genomic Price Rate Of Daily Change 0.99 

ARK Genomic January 18, 2025 Etf Price Analysis

When benchmark price declines in a down market, there may be an uptick in ARK Genomic Revolution Etf price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use ARK Genomic intraday prices and daily technical indicators to check the level of noise trading in ARK Genomic Revolution Etf and then apply it to test your longer-term investment strategies against ARK.

ARK Etf Price History Data

The price series of ARK Genomic for the period between Sun, Oct 20, 2024 and Sat, Jan 18, 2025 has a statistical range of 4.45 with a coefficient of variation of 4.37. The prices are distributed with arithmetic mean of 24.65. The median price for the last 90 days is 24.66. The company issued dividends on 27th of December 2019.
OpenHighLowCloseVolume
01/18/2025
 24.44  24.61  24.03  24.11 
01/17/2025 24.44  24.61  24.03  24.11  1,612,172 
01/16/2025 24.56  24.59  23.87  24.25  2,491,507 
01/15/2025 24.54  25.23  24.20  24.43  4,899,517 
01/14/2025 24.82  25.00  23.50  23.61  4,411,200 
01/13/2025 24.34  24.49  23.64  24.46  2,974,626 
01/10/2025 25.06  25.06  24.23  24.74  4,522,165 
01/08/2025 25.82  25.87  25.08  25.57  3,032,865 
01/07/2025 26.40  27.10  25.46  25.59  4,816,233 
01/06/2025 25.92  26.71  25.86  26.16  2,943,800 
01/03/2025 24.72  25.83  24.64  25.68  2,445,757 
01/02/2025 23.85  24.83  23.57  24.46  2,675,215 
12/31/2024 23.83  24.06  23.40  23.55  2,331,000 
12/30/2024 24.06  24.06  23.45  23.71  2,134,345 
12/27/2024 24.81  25.03  24.01  24.43  2,472,412 
12/26/2024 23.92  24.79  23.78  24.66  1,587,900 
12/24/2024 24.07  24.24  23.69  24.18  659,436 
12/23/2024 23.77  24.01  23.27  23.97  2,110,749 
12/20/2024 22.80  24.04  22.72  23.68  6,841,827 
12/19/2024 23.15  23.19  22.54  22.95  4,290,900 
12/18/2024 24.85  24.89  22.47  22.90  7,071,119 
12/17/2024 25.16  25.42  24.61  24.70  3,602,000 
12/16/2024 24.77  25.60  24.56  25.23  1,583,461 
12/13/2024 25.11  25.20  24.39  24.71  3,688,808 
12/12/2024 26.00  26.12  25.14  25.15  2,057,219 
12/11/2024 26.97  26.97  25.87  26.13  1,789,202 
12/10/2024 26.47  27.05  26.34  26.52  1,668,739 
12/09/2024 26.86  27.36  26.41  26.41  2,673,633 
12/06/2024 25.53  26.74  25.51  26.43  3,643,800 
12/05/2024 26.06  26.06  25.17  25.20  1,717,805 
12/04/2024 25.82  26.53  25.43  26.13  3,028,236 
12/03/2024 26.35  26.35  25.57  25.70  2,001,375 
12/02/2024 26.11  26.80  26.01  26.69  2,210,038 
11/29/2024 25.63  26.09  25.41  25.98  1,280,600 
11/27/2024 25.06  25.58  25.06  25.43  1,815,403 
11/26/2024 24.94  24.99  24.49  24.84  1,405,795 
11/25/2024 24.46  25.40  24.40  25.06  3,565,186 
11/22/2024 23.33  24.00  23.04  23.83  2,632,673 
11/21/2024 23.44  23.51  22.85  23.22  1,701,297 
11/20/2024 23.53  23.59  22.97  23.36  2,231,501 
11/19/2024 22.51  23.27  22.27  23.26  2,745,573 
11/18/2024 23.11  23.16  22.53  22.68  4,325,838 
11/15/2024 24.25  24.25  22.63  22.66  4,991,600 
11/14/2024 25.66  25.71  24.10  24.13  3,901,900 
11/13/2024 26.45  26.83  25.61  25.65  2,100,518 
11/12/2024 26.77  27.07  25.86  26.00  1,944,077 
11/11/2024 26.33  27.73  26.27  27.11  5,237,729 
11/08/2024 25.40  26.00  25.29  25.90  2,532,400 
11/07/2024 25.70  26.07  25.36  25.39  2,255,697 
11/06/2024 25.36  25.61  24.82  25.49  2,478,876 
11/05/2024 24.07  24.78  23.64  24.78  3,833,691 
11/04/2024 23.95  24.39  23.67  24.27  1,711,011 
11/01/2024 23.37  24.00  23.33  24.00  3,938,848 
10/31/2024 23.78  23.89  23.14  23.14  2,828,774 
10/30/2024 23.74  24.31  23.65  24.00  860,400 
10/29/2024 23.95  23.98  23.69  23.94  1,473,237 
10/28/2024 23.47  24.31  23.42  24.06  1,691,653 
10/25/2024 23.40  23.78  23.21  23.30  1,954,145 
10/24/2024 23.58  23.66  23.17  23.29  3,180,903 
10/23/2024 23.98  24.06  23.35  23.55  2,255,489 
10/22/2024 24.17  24.26  24.00  24.07  1,423,240 

About ARK Genomic Etf history

ARK Genomic investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ARK is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ARK Genomic Revolution will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ARK Genomic stock prices may prove useful in developing a viable investing in ARK Genomic
The fund is an actively-managed exchange-traded fund that will invest under normal circumstances primarily in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the funds investment theme of the genomics revolution . Ark Genomic is traded on BATS Exchange in the United States.

ARK Genomic Etf Technical Analysis

ARK Genomic technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
A focus of ARK Genomic technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of ARK Genomic trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Price Ceiling Movement Now

   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
All  Next Launch Module

ARK Genomic Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for ARK Genomic's price direction in advance. Along with the technical and fundamental analysis of ARK Etf historical price patterns, it is also worthwhile for investors to track various predictive indicators of ARK to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether ARK Genomic Revolution is a strong investment it is important to analyze ARK Genomic's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ARK Genomic's future performance. For an informed investment choice regarding ARK Etf, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ARK Genomic Revolution. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in industry.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
The market value of ARK Genomic Revolution is measured differently than its book value, which is the value of ARK that is recorded on the company's balance sheet. Investors also form their own opinion of ARK Genomic's value that differs from its market value or its book value, called intrinsic value, which is ARK Genomic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ARK Genomic's market value can be influenced by many factors that don't directly affect ARK Genomic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ARK Genomic's value and its price as these two are different measures arrived at by different means. Investors typically determine if ARK Genomic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ARK Genomic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.